Recently, the synergistic effects of HDAC inhibitors and conventional chemotherapeutic agents have been studied17, which showed that a combination of gemcitabine and HDAC inhibitors potently enhanced gemcitabine-mediated growth inhibition and apoptosis in pancreatic cancer cells9, 18, 19. Here, HDAC9 is linked to familial pancreatic carcinoma.